<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37606045</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>Ancestry-based differences in the immune phenotype are associated with lupus activity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e169584</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.169584</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) affects 1 in 537 Black women, which is &gt;2-fold more than White women. Black patients develop the disease at a younger age, have more severe symptoms, and have a greater chance of early mortality. We used a multiomics approach to uncover ancestry-associated immune alterations in patients with SLE and healthy controls that may contribute biologically to disease disparities. Cell composition, signaling, epigenetics, and proteomics were evaluated by mass cytometry; droplet-based single-cell transcriptomics and proteomics; and bead-based multiplex soluble mediator levels in plasma. We observed altered whole blood frequencies and enhanced activity in CD8+ T cells, B cells, monocytes, and DCs in Black patients with more active disease. Epigenetic modifications in CD8+ T cells (H3K27ac) could distinguish disease activity level in Black patients and differentiate Black from White patient samples. TLR3/4/7/8/9-related gene expression was elevated in immune cells from Black patients with SLE, and TLR7/8/9 and IFN-&#x3b1; phospho-signaling and cytokine responses were heightened even in immune cells from healthy Black control patients compared with White individuals. TLR stimulation of healthy immune cells recapitulated the ancestry-associated SLE immunophenotypes. This multiomic resource defines ancestry-associated immune phenotypes that differ between Black and White patients with SLE, which may influence the course and severity of SLE and other diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Slight-Webb</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Miles</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Catriona A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macwana</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bylinska</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donato</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Department of Medicine; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dvorak</LastName><ForeName>Mai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Department of Medicine; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Peggie</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalesinskas</LastName><ForeName>Laurynas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Department of Medicine; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesan</LastName><ForeName>Ananthakrishnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Department of Medicine; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dermadi</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Department of Medicine; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guthridge</LastName><ForeName>Carla J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeJager</LastName><ForeName>Wade</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foecke</LastName><ForeName>Mariko H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merrill</LastName><ForeName>Joan T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakravarty</LastName><ForeName>Eliza</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arriens</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maecker</LastName><ForeName>Holden T</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khatri</LastName><ForeName>Purvesh</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Department of Medicine; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Utz</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Judith A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guthridge</LastName><ForeName>Joel M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI082714</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI144292</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR073750</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI110491</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007633</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR072401</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="Y">B-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044383" MajorTopicYN="N">Black People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">Lupus</Keyword><Keyword MajorTopicYN="N">Signal transduction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>7</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37606045</ArticleId><ArticleId IdType="pmc">PMC10543734</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.169584</ArticleId><ArticleId IdType="pii">169584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gergianaki I, et al. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2018;32(2):188&#x2013;205. doi: 10.1016/j.berh.2018.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2018.09.004</ArticleId><ArticleId IdType="pubmed">30527426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MJ, Jawad AS. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford) 2017;56(suppl 1):67&#x2013;i77.</Citation><ArticleIdList><ArticleId IdType="pubmed">27940583</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2):144&#x2013;150. doi: 10.1097/BOR.0000000000000480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000480</ArticleId><ArticleId IdType="pmc">PMC6026543</ArticleId><ArticleId IdType="pubmed">29251660</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen EY, Singh RR. Brief report: lupus-an unrecognized leading cause of death in young females: a population-based study using nationwide death certificates, 2000-2015. Arthritis Rheumatol. 2018;70(8):1251&#x2013;1255. doi: 10.1002/art.40512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40512</ArticleId><ArticleId IdType="pmc">PMC6105528</ArticleId><ArticleId IdType="pubmed">29671279</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarcon GS, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998;41(7):1173&#x2013;1180. doi: 10.1002/1529-0131(199807)41:7&lt;1173::AID-ART5&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199807)41:7&lt;1173::AID-ART5&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">9663472</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillatreau S, et al. Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(2):98&#x2013;108. doi: 10.1038/s41584-020-00544-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00544-4</ArticleId><ArticleId IdType="pmc">PMC7747191</ArticleId><ArticleId IdType="pubmed">33339987</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen SR, et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25(3):417&#x2013;428. doi: 10.1016/j.immuni.2006.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.07.013</ArticleId><ArticleId IdType="pubmed">16973389</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossaller L, et al. TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in pristane-induced murine lupus. J Immunol. 2016;197(4):1044&#x2013;1053. doi: 10.4049/jimmunol.1501943.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501943</ArticleId><ArticleId IdType="pmc">PMC5266544</ArticleId><ArticleId IdType="pubmed">27354219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickerson KM, et al. Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice. PLoS One. 2017;12(3):e0173471. doi: 10.1371/journal.pone.0173471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0173471</ArticleId><ArticleId IdType="pmc">PMC5344451</ArticleId><ArticleId IdType="pubmed">28278279</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortezagholi S, et al. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-&#x3b1; production in SLE patients. Immunopharmacol Immunotoxicol. 2017;39(1):11&#x2013;18. doi: 10.1080/08923973.2016.1263859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08923973.2016.1263859</ArticleId><ArticleId IdType="pubmed">28049380</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata K, et al. Up-regulation of TLR7-mediated IFN-&#x3b1; production by plasmacytoid dendritic cells in patients with systemic lupus erythematosus. Front Immunol. 2018;9:1957. doi: 10.3389/fimmu.2018.01957.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01957</ArticleId><ArticleId IdType="pmc">PMC6121190</ArticleId><ArticleId IdType="pubmed">30210502</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsuda A, et al. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol. 2008;152(3):482&#x2013;487. doi: 10.1111/j.1365-2249.2008.03646.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2008.03646.x</ArticleId><ArticleId IdType="pmc">PMC2453201</ArticleId><ArticleId IdType="pubmed">18373699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyn-Cook BD, et al. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Mol Immunol. 2014;61(1):38&#x2013;43. doi: 10.1016/j.molimm.2014.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2014.05.001</ArticleId><ArticleId IdType="pubmed">24865418</ArticleId></ArticleIdList></Reference><Reference><Citation>Menard LC, et al. B cells from African American lupus patients exhibit an activated phenotype. JCI Insight. 2016;1(9):87310. doi: 10.1172/jci.insight.87310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.87310</ArticleId><ArticleId IdType="pmc">PMC5033941</ArticleId><ArticleId IdType="pubmed">27699274</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks SA, et al. Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity. 2018;49(4):725&#x2013;739. doi: 10.1016/j.immuni.2018.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.08.015</ArticleId><ArticleId IdType="pmc">PMC6217820</ArticleId><ArticleId IdType="pubmed">30314758</ArticleId></ArticleIdList></Reference><Reference><Citation>Weckerle CE, et al. Network analysis of associations between serum interferon-&#x3b1; activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011;63(4):1044&#x2013;1053. doi: 10.1002/art.30187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30187</ArticleId><ArticleId IdType="pmc">PMC3068224</ArticleId><ArticleId IdType="pubmed">21162028</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalina MD, et al. Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus. JCI Insight. 2020;5(15):e140380. doi: 10.1172/jci.insight.140380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140380</ArticleId><ArticleId IdType="pmc">PMC7455079</ArticleId><ArticleId IdType="pubmed">32759501</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman DS, et al. Black/white differences in leukocyte subpopulations in men. Int J Epidemiol. 1997;26(4):757&#x2013;764. doi: 10.1093/ije/26.4.757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/26.4.757</ArticleId><ArticleId IdType="pubmed">9279607</ArticleId></ArticleIdList></Reference><Reference><Citation>Beutler E, West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood. 2005;106(2):740&#x2013;745. doi: 10.1182/blood-2005-02-0713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-02-0713</ArticleId><ArticleId IdType="pmc">PMC1895180</ArticleId><ArticleId IdType="pubmed">15790781</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollerud DJ, et al. The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers. J Clin Immunol. 1989;9(3):214&#x2013;222. doi: 10.1007/BF00916817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00916817</ArticleId><ArticleId IdType="pubmed">2788656</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelec Y, et al. Genetic ancestry and natural selection drive population differences in immune responses to pathogens. Cell. 2016;167(3):657&#x2013;669. doi: 10.1016/j.cell.2016.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.09.025</ArticleId><ArticleId IdType="pubmed">27768889</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph HE, et al. Genetic ancestry effects on the response to viral infection are pervasive but cell type specific. Science. 2021;374(6571):1127&#x2013;1133. doi: 10.1126/science.abg0928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg0928</ArticleId><ArticleId IdType="pmc">PMC8957271</ArticleId><ArticleId IdType="pubmed">34822289</ArticleId></ArticleIdList></Reference><Reference><Citation>Slight-Webb S, et al. Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype. J Allergy Clin Immunol. 2020;146(6):1419&#x2013;1433. doi: 10.1016/j.jaci.2020.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.04.047</ArticleId><ArticleId IdType="pmc">PMC7680268</ArticleId><ArticleId IdType="pubmed">32446964</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks J, et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol. 2000;1(5):433&#x2013;440. doi: 10.1038/80877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/80877</ArticleId><ArticleId IdType="pubmed">11062504</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K, Cerutti A. New insights into the enigma of immunoglobulin D. Immunol Rev. 2010;237(1):160&#x2013;179. doi: 10.1111/j.1600-065X.2010.00929.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2010.00929.x</ArticleId><ArticleId IdType="pmc">PMC3048779</ArticleId><ArticleId IdType="pubmed">20727035</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutzeit C, et al. The enigmatic function of IgD: some answers at last. Eur J Immunol. 2018;48(7):1101&#x2013;1113. doi: 10.1002/eji.201646547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201646547</ArticleId><ArticleId IdType="pmc">PMC6033660</ArticleId><ArticleId IdType="pubmed">29733429</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung P, et al. Single-cell epigenetics - chromatin modification atlas unveiled by mass cytometry. Clin Immunol. 2018;196:40&#x2013;48. doi: 10.1016/j.clim.2018.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2018.06.009</ArticleId><ArticleId IdType="pmc">PMC6422338</ArticleId><ArticleId IdType="pubmed">29960011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung P, et al. Single-cell chromatin modification profiling reveals increased epigenetic variations with aging. Cell. 2018;173(6):1385&#x2013;1397. doi: 10.1016/j.cell.2018.03.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.079</ArticleId><ArticleId IdType="pmc">PMC5984186</ArticleId><ArticleId IdType="pubmed">29706550</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaussabel D, Baldwin N. Democratizing systems immunology with modular transcriptional repertoire analyses. Nat Rev Immunol. 2014;14(4):271&#x2013;280. doi: 10.1038/nri3642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3642</ArticleId><ArticleId IdType="pmc">PMC4118927</ArticleId><ArticleId IdType="pubmed">24662387</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau R, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165(3):551&#x2013;565. doi: 10.1016/j.cell.2016.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.03.008</ArticleId><ArticleId IdType="pmc">PMC5426482</ArticleId><ArticleId IdType="pubmed">27040498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehar-Belaid D, et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol. 2020;21(9):1094&#x2013;1106. doi: 10.1038/s41590-020-0743-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0743-0</ArticleId><ArticleId IdType="pmc">PMC7442743</ArticleId><ArticleId IdType="pubmed">32747814</ArticleId></ArticleIdList></Reference><Reference><Citation>van Duin D, et al. Age-associated defect in human TLR-1/2 function. J Immunol. 2007;178(2):970&#x2013;975. doi: 10.4049/jimmunol.178.2.970.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.2.970</ArticleId><ArticleId IdType="pubmed">17202359</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlson EW, et al. A connective tissue disease screening questionnaire for population studies. Ann Epidemiol. 1995;5(4):297&#x2013;302. doi: 10.1016/1047-2797(94)00096-C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1047-2797(94)00096-C</ArticleId><ArticleId IdType="pubmed">8520712</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennington R, et al. Group differences in proneness to inflammation. Infect Genet Evol. 2009;9(6):1371&#x2013;1380. doi: 10.1016/j.meegid.2009.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2009.09.017</ArticleId><ArticleId IdType="pubmed">19804845</ArticleId></ArticleIdList></Reference><Reference><Citation>Doumas M, et al. COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute? J Hum Hypertens. 2020;34(11):764&#x2013;767. doi: 10.1038/s41371-020-0380-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-020-0380-y</ArticleId><ArticleId IdType="pmc">PMC7363409</ArticleId><ArticleId IdType="pubmed">32669668</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancy CW. COVID-19 and African Americans. JAMA. 2020;323(19):1891&#x2013;1892. doi: 10.1001/jama.2020.6548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6548</ArticleId><ArticleId IdType="pubmed">32293639</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchene J, et al. Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis. Nat Immunol. 2017;18(7):753&#x2013;761. doi: 10.1038/ni.3763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3763</ArticleId><ArticleId IdType="pmc">PMC5480598</ArticleId><ArticleId IdType="pubmed">28553950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ness RB, et al. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. Am J Epidemiol. 2004;160(11):1033&#x2013;1038. doi: 10.1093/aje/kwh325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh325</ArticleId><ArticleId IdType="pubmed">15561982</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley ITW, et al. 1401 A genome wide association scan of SLE genetic risk in a cohort of African-American persons. Lupus Sci Med. 2022;9(suppl 3):A92&#x2013;A93.</Citation></Reference><Reference><Citation>Lanata CM, et al. Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients. PLoS One. 2018;13(6):e0199003. doi: 10.1371/journal.pone.0199003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0199003</ArticleId><ArticleId IdType="pmc">PMC6023154</ArticleId><ArticleId IdType="pubmed">29953444</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaney AS, et al. Coprevalence of Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type-1 antibodies among United States children and factors associated with their acquisition. J Pediatric Infect Dis Soc. 2015;4(4):323&#x2013;329. doi: 10.1093/jpids/piu076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piu076</ArticleId><ArticleId IdType="pubmed">26582871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritterhouse LL, et al. B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels. Arthritis Rheum. 2011;63(12):3931&#x2013;3941. doi: 10.1002/art.30598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30598</ArticleId><ArticleId IdType="pmc">PMC3234134</ArticleId><ArticleId IdType="pubmed">22127709</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamoto T, et al. Associations between type I interferon and antiphospholipid antibody status differ between ancestral backgrounds. Lupus Sci Med. 2018;5(1):e000246. doi: 10.1136/lupus-2017-000246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2017-000246</ArticleId><ArticleId IdType="pmc">PMC5786906</ArticleId><ArticleId IdType="pubmed">29387437</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe SR, et al. Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum. 2011;63(8):2396&#x2013;2406. doi: 10.1002/art.30388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30388</ArticleId><ArticleId IdType="pmc">PMC3149742</ArticleId><ArticleId IdType="pubmed">21598235</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangye SG, et al. Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol. 2002;169(8):4298&#x2013;4306. doi: 10.4049/jimmunol.169.8.4298.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.8.4298</ArticleId><ArticleId IdType="pubmed">12370361</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmers F, et al. The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. Cell. 2021;184(15):3915&#x2013;3935. doi: 10.1016/j.cell.2021.05.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.05.039</ArticleId><ArticleId IdType="pmc">PMC8316438</ArticleId><ArticleId IdType="pubmed">34174187</ArticleId></ArticleIdList></Reference><Reference><Citation>Psarras A, et al. Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity. Nat Commun. 2020;11(1):6149. doi: 10.1038/s41467-020-19918-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19918-z</ArticleId><ArticleId IdType="pmc">PMC7708979</ArticleId><ArticleId IdType="pubmed">33262343</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae DH, et al. Telomere length predicts mortality in the Black Womens Experiences Living with Lupus (BeWELL) Study. J Immunol. 2020;204(suppl 1):224.52. doi: 10.4049/jimmunol.204.Supp.224.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.204.Supp.224.52</ArticleId></ArticleIdList></Reference><Reference><Citation>Pego-Reigosa JM, et al. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology (Oxford) 2021;60(1):60&#x2013;72. doi: 10.1093/rheumatology/keaa478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa478</ArticleId><ArticleId IdType="pmc">PMC7785308</ArticleId><ArticleId IdType="pubmed">33099651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZQ, et al. Long-term survival and death causes of systemic lupus erythematosus in China a systemic review of observational studiesc. Medicine. 2015;94(17):e794. doi: 10.1097/MD.0000000000000794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000000794</ArticleId><ArticleId IdType="pmc">PMC4603034</ArticleId><ArticleId IdType="pubmed">25929930</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldblatt F, et al. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus. 2009;18(8):682&#x2013;689. doi: 10.1177/0961203308101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308101019</ArticleId><ArticleId IdType="pubmed">19502263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718&#x2013;724. doi: 10.1126/science.abc6027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Teijaro JR. Type I interferons in viral control and immune regulation. Curr Opin Virol. 2016;16:31&#x2013;40. doi: 10.1016/j.coviro.2016.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2016.01.001</ArticleId><ArticleId IdType="pmc">PMC4821698</ArticleId><ArticleId IdType="pubmed">26812607</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusnadi A, et al. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells. Sci Immunol. 2021;6(55):eabe4782. doi: 10.1126/sciimmunol.abe4782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe4782</ArticleId><ArticleId IdType="pmc">PMC8101257</ArticleId><ArticleId IdType="pubmed">33478949</ArticleId></ArticleIdList></Reference><Reference><Citation>Maucourant C, et al. Natural killer cell immunotypes related to COVID-19 disease severity. Sci Immunol. 2020;5(50):eabd6832. doi: 10.1126/sciimmunol.abd6832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd6832</ArticleId><ArticleId IdType="pmc">PMC7665314</ArticleId><ArticleId IdType="pubmed">32826343</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann ND, et al. Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children. Nat Commun. 2021;12(1):4854. doi: 10.1038/s41467-021-24981-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24981-1</ArticleId><ArticleId IdType="pmc">PMC8357784</ArticleId><ArticleId IdType="pubmed">34381049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurupati R, et al. Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood. Oncotarget. 2016;7(39):62898&#x2013;62911. doi: 10.18632/oncotarget.11704.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.11704</ArticleId><ArticleId IdType="pmc">PMC5325335</ArticleId><ArticleId IdType="pubmed">27588486</ArticleId></ArticleIdList></Reference><Reference><Citation>Haralambieva IH, et al. Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts. Vaccine. 2014;32(17):1946&#x2013;1953. doi: 10.1016/j.vaccine.2014.01.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.01.090</ArticleId><ArticleId IdType="pmc">PMC3980440</ArticleId><ArticleId IdType="pubmed">24530932</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuillan GM, et al. Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis. 2007;196(10):1459&#x2013;1464. doi: 10.1086/522866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/522866</ArticleId><ArticleId IdType="pubmed">18008224</ArticleId></ArticleIdList></Reference><Reference><Citation>Christy C, et al. Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines. Pediatrics. 1995;96(3 pt 2):584&#x2013;587. doi: 10.1542/peds.96.3.584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.96.3.584</ArticleId><ArticleId IdType="pubmed">7659481</ArticleId></ArticleIdList></Reference><Reference><Citation>Price AL, et al. Discerning the ancestry of European Americans in genetic association studies. PLoS Genet. 2008;4(1):e236. doi: 10.1371/journal.pgen.0030236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0030236</ArticleId><ArticleId IdType="pmc">PMC2211542</ArticleId><ArticleId IdType="pubmed">18208327</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677&#x2013;2686. doi: 10.1002/art.34473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Slight-Webb S, et al. Autoantibody-positive healthy individuals display unique immune profiles that may regulate autoimmunity. Arthritis Rheumatol. 2016;68(10):2492&#x2013;2502. doi: 10.1002/art.39706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39706</ArticleId><ArticleId IdType="pmc">PMC5042816</ArticleId><ArticleId IdType="pubmed">27059145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheir JM, et al. Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus. Lupus Sci Med. 2018;5(1):e000247. doi: 10.1136/lupus-2017-000247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2017-000247</ArticleId><ArticleId IdType="pmc">PMC5844376</ArticleId><ArticleId IdType="pubmed">29531773</ArticleId></ArticleIdList></Reference><Reference><Citation>Li QZ, et al. Risk factors for ANA positivity in healthy persons. Arthritis Res Ther. 2011;13(2):R38. doi: 10.1186/ar3271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3271</ArticleId><ArticleId IdType="pmc">PMC3132017</ArticleId><ArticleId IdType="pubmed">21366908</ArticleId></ArticleIdList></Reference><Reference><Citation>Amir el AD, et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol. 2013;31(6):545&#x2013;552. doi: 10.1038/nbt.2594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2594</ArticleId><ArticleId IdType="pmc">PMC4076922</ArticleId><ArticleId IdType="pubmed">23685480</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>